eLearning Courses

How to Access the Courses

  • Step 1: Register for the Curriculum
    • All participants must register for the curriculum to gain access to the courses
    • Click the “Register for the Curriculum” button above
    • Complete the form fields to register for the curriculum and create an account
    • Click “Submit”
    • If you already have an account: Click “Log-in” at the top right of the form. Complete the form if you are prompted to – this will register your account for the curriculum. Click “Submit”.
  • Step 2: Access Individual Courses
    • After you have registered for the curriculum by following the steps above, you can access the modules by either:
      • Logging in to the learning management system and finding the courses under “Learning”, or
      • Returning to this page, selecting one of the courses below, and clicking “Open Course”

Target Audience

This activity is intended for prescribers and other healthcare professionals engaged in safe and effective prescribing practices and care of patients with opioid use disorder in primary care and other healthcare settings.

Educational Objectives

After completing this activity, the participant should be better able to:

Faculty

Diana Coffa, MD
Heather Tick
Debra Gordon, RN, DNP, FAAN
Elizabeth Habermann, PhD, MPH
Don Teater, MD
Jenifer Jackson, MS
Rebecca Vargas-Jackson, MD

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ per module. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education per module.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours (per module).

NAADAC credit

This course has been approved by the Postgraduate Institute for Medicine, as a NAADAC Approved Education Provider, for educational credits (1.0 per module). NAADAC Provider #144331, Postgraduate Institute for Medicine is responsible for all aspects of the programming.

CPH Credit

Postgraduate Institute for Medicine (PIM) is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Public health professionals will receive 1.0 CPH credits (per module) for participating in this activity.

AAPA Credit Designation Statement

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 9/27/2020. PAs should only claim credit commensurate with the extent of their participation.

Social Worker Education

As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 clinical continuing education credits (per module).

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Heather Tick
Royalty from “Holistic Pain Relief”, New World Library (publisher)

Elizabeth Habermann, PhD MPH
Salary from Mayo Clinic

All other faculty have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The HealthHIV planners and managers have nothing to disclose.

Method of Participation and Request for Credit

Participants must read the learning objectives, faculty disclosures, and complete each educational activity. Once each activity is completed, you must pass the post-test with a score of 80% or better, and complete the online evaluation form. Upon successful completion of each activity, you will be provided an immediate certificate to download or print for your files.

For Pharmacists: Upon successfully completing the post-test with a score of 80% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.